Novanta Inc., a global technology partner for medical and advanced technology equipment manufacturers, has announced that its Chair & CEO Matthijs Glastra and Chief Financial Officer Robert Buckley will present at the Baird 2025 Global Healthcare Conference on September 9, 2025, in New York, NY. The company specializes in providing precision medicine, robotics, automation, and advanced surgery solutions to original equipment manufacturers in the medical and life science industries.

The global Surgical Instrument Tracking Systems (SITS) market is projected to grow from $292.4 million in 2024 to $1,162.5 million by 2034, at a compound annual growth rate (CAGR) of 14.8%. North America led the market in 2024 with a 37.4% share and $109.4 million in revenue, driven by advanced healthcare infrastructure, strict regulatory frameworks like FDA’s UDI mandate, and high surgical volumes. The market is primarily driven by patient safety, operational efficiency, and compliance with sterilization standards. RFID technology dominates the technology segment with a 51.3% market share, outperforming barcode and electronic tracking methods. Hospitals account for 54.5% of total revenue as the primary end-user segment. Key players include Fortive Corporation, Becton, Dickinson and Company (BD), Getinge AB, STERIS plc, and STANLEY Healthcare (CenTrak). Notable partnerships include Novanta Inc. and Identiv, Inc., which launched an RFID-powered collaboration in February 2025. Emerging trends include integration with hospital information systems, cloud-based and mobile solutions, predictive analytics, and a strong focus on preventing retained surgical items (RSIs). The market is expanding globally, particularly in Asia-Pacific and Latin America, due to healthcare infrastructure modernization.

Novanta Inc. reported Q2 2025 earnings that exceeded expectations, with revenue of $241 million surpassing FactSet's estimate of $238 million and adjusted EPS of $0.76 beating the $0.73 forecast. The company also provided Q3 2025 guidance, projected revenue between $244M and $247M, and adjusted EPS between $0.78 and $0.85. Key events include the acquisition of Keonn Technologies for €60.6 million and a strategic partnership with Identiv for RFID solutions in healthcare.

Brown Advisory Inc. reduced its stake in Novanta Inc. (NASDAQ:NOVT) by 41.8% in Q1, while other institutional investors increased their holdings. Novanta reported Q2 earnings of $0.74 EPS, exceeding expectations, with a market cap of $4.49 billion. Wall Street Zen upgraded Novanta to a 'buy' rating.

Bank of New York Mellon Corp reduced its stake in Novanta Inc. by 5.5% in Q1, while other institutional investors adjusted their holdings. Novanta reported Q2 earnings exceeding estimates, with a 1.1% revenue increase and a 63.63 P/E ratio. Wall Street Zen upgraded Novanta's rating to 'buy' following strong performance.